Clinical Trials Browser

OTHER × Hodgkin Disease × Transplantation Conditioning × Clear all

NCT02378922 2018-12-27

Gene-Modified HIV-Protected Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma

Phase 1 Withdrawn

Hodgkin Disease, Lymphoma, Non-Hodgkin, HIV Infections